Offering biomedical innovators the experience, expertise, and funding required for success.
Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge. Learn more ›
RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics. Many of these life science tools are available from RCT through affordable nonexclusive licensing. Learn more ›
BEVERLY, Mass., /PRNewswire/ — seqWell is excited to announce the appointment of Dan Calvo as its President and Chief Executive Officer, effective as of April 19th, 2021. Dan brings over 30 years of leadership experience, most recently serving as President … Learn more